Amgen, Inc. (AMGN)
467.06
-1.05
(-0.22%)
USD |
NASDAQ |
Nov 12, 16:00
469.13
+2.07
(+0.44%)
After-Hours: 04:33
Amgen EPS Diluted (Quarterly) : 7.077 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 7.077 |
| June 30, 2026 | 4.366 |
| March 31, 2026 | 3.344 |
| December 31, 2025 | 2.455 |
| September 30, 2025 | 5.934 |
| June 30, 2025 | 2.647 |
| March 31, 2025 | 3.198 |
| December 31, 2024 | 1.157 |
| September 30, 2024 | 5.221 |
| June 30, 2024 | 1.379 |
| March 31, 2024 | -0.2108 |
| December 31, 2023 | 1.420 |
| September 30, 2023 | 3.216 |
| June 30, 2023 | 2.568 |
| March 31, 2023 | 5.281 |
| December 31, 2022 | 2.998 |
| September 30, 2022 | 3.983 |
| June 30, 2022 | 2.452 |
| March 31, 2022 | 2.679 |
| December 31, 2021 | 3.361 |
| September 30, 2021 | 3.305 |
| June 30, 2021 | 0.8056 |
| March 31, 2021 | 2.833 |
| December 31, 2020 | 2.761 |
| September 30, 2020 | 3.431 |
| Date | Value |
|---|---|
| June 30, 2020 | 3.046 |
| March 31, 2020 | 3.072 |
| December 31, 2019 | 2.848 |
| September 30, 2019 | 3.269 |
| June 30, 2019 | 3.572 |
| March 31, 2019 | 3.182 |
| December 31, 2018 | 3.012 |
| September 30, 2018 | 2.864 |
| June 30, 2018 | 3.479 |
| March 31, 2018 | 3.250 |
| December 31, 2017 | -5.890 |
| September 30, 2017 | 2.757 |
| June 30, 2017 | 2.915 |
| March 31, 2017 | 2.795 |
| December 31, 2016 | 2.587 |
| September 30, 2016 | 2.679 |
| June 30, 2016 | 2.474 |
| March 31, 2016 | 2.50 |
| December 31, 2015 | 2.365 |
| September 30, 2015 | 2.438 |
| June 30, 2015 | 2.152 |
| March 31, 2015 | 2.108 |
| December 31, 2014 | 1.68 |
| September 30, 2014 | 1.61 |
| June 30, 2014 | 2.01 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 1.942 |
| Regeneron Pharmaceuticals, Inc. | 18.45 |
| AbbVie, Inc. | 2.373 |
| Biogen, Inc. | -0.1394 |
| Vertex Pharmaceuticals, Inc. | 2.561 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.864B |
| Revenue (Quarterly) | 10.36B |
| Total Expenses (Quarterly) | 6.497B |
| Enterprise Value | 293.45B |
| Gross Profit Margin (Quarterly) | 73.09% |
| Profit Margin (Quarterly) | 37.29% |
| Earnings Yield | 3.69% |
| Operating Earnings Yield | 5.46% |
| Normalized Earnings Yield | 4.022 |